Arimidex in McCune Albright Syndrome
NCT00055302
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
McCune-Albright Syndrome
Interventions
DRUG:
Arimidex 1 mg
Sponsor
AstraZeneca